EligibleTrials
Drugs & treatments › Axl/Mer/CSF1R Inhibitor Q702

Axl/Mer/CSF1R Inhibitor Q702: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1
Recruiting trials
15
Conditions studied
2
US states with sites
1
Countries

Phase breakdown

Phase 1 1

Conditions being studied

ConditionTrials
Hematopoietic and Lymphatic System Neoplasm1
Histiocytic Sarcoma1
Lung cancer1
Malignant Histiocytosis1
Peripheral T-Cell Lymphoma, Not Otherwise Specified1
Primary Central Nervous System Lymphoma1
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma1
Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm1
Recurrent Chronic Lymphocytic Leukemia1
Recurrent Chronic Myelomonocytic Leukemia1
Recurrent Erdheim-Chester Disease1
Recurrent Fibroblastic Reticular Cell Sarcoma1
Recurrent Follicular Lymphoma1
Recurrent Histiocytic Sarcoma1
Recurrent Interdigitating Dendritic Cell Sarcoma1

Recruiting trials involving Axl/Mer/CSF1R Inhibitor Q702

Common questions

How many recruiting trials involve Axl/Mer/CSF1R Inhibitor Q702?

1 recruiting trial across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.